Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021)
Idexx Laboratories (IDXX) posted Income from Non-Controlling Interests of -$57000.0 for Q3 2021, down 337.5% on a QoQ basis from $24000.0 in Q2 2021, and down 155.88% year-over-year from $102000.0 in Q3 2020.
Powered by 
Analysis
Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021) Analysis & Trends
Idexx Laboratories has reported Income from Non-Controlling Interests for 12 years, with the latest figure at -$57000.0 in Q3 2021.
- On a quarterly basis, Income from Non-Controlling Interests fell 155.88% year-over-year to -$57000.0 in Q3 2021; TTM through Jun 2022 was -$57000.0, a 117.48% decrease from a year earlier, with the FY2021 full-year figure at -$1000.0, down 100.28% from the prior year.
- Income from Non-Controlling Interests was -$57000.0 for Q3 2021 at Idexx Laboratories, down from $24000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $168000.0 in Q4 2020, with the low at -$57000.0 in Q3 2021.
- Average Income from Non-Controlling Interests over 5 years is $29842.1, with a median of $29000.0 recorded in 2020.
- The sharpest annual moves came in 2018 and 2020: Income from Non-Controlling Interests tumbled 1333.33% in 2018, then surged 10100.0% in 2020.
- Over 5 years, Income from Non-Controlling Interests stood at $33000.0 in 2017, then rose by 18.18% to $39000.0 in 2018, then grew by 23.08% to $48000.0 in 2019, then soared by 250.0% to $168000.0 in 2020, then slumped by 133.93% to -$57000.0 in 2021.
- The last three Income from Non-Controlling Interests figures came in at -$57000.0 (Q3 2021), $24000.0 (Q2 2021), and $32000.0 (Q1 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | - |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | - |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -57,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | 168,000.00 |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 29,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | -5,000.00 |
| Mar 31, 2019 | 28,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | -37,000.00 |
| Jun 30, 2018 | -11,000.00 |
| Mar 31, 2018 | 25,000.00 |
| Dec 31, 2017 | 33,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | 2,000.00 |